Comprehensive Bioinformatics Analysis of Human Matrix Metalloproteinase-9 (MMP9): Sequence Analysis, Structural Characterization, and Functional Annotation

Matrix metalloproteinase-9 (MMP9) is a zinc-dependent endopeptidase that plays a crucial role in extracellular matrix remodeling, inflammation, and cancer metastasis. This study presents a comprehensive bioinformatics analysis of the human MMP9 protein (UniProt ID: P14780), encompassing sequence analysis, physicochemical characterization, domain architecture, posttranslational modifications, genetic variants, and functional annotations. The 707-amino acid protein has a calculated molecular weight of 78,458 Da and an isoelectric point of 7.02, indicating near-neutral charge at physiological pH. Domain architecture analysis revealed a conserved structural organization comprising a signal peptide (residues 1-19), propeptide (20-93), three fibronectin type-II repeats (225-390), and four hemopexin-like domains (518-704). The catalytic domain contains the canonical zinc-binding motif HEXXHXXGXXH with Glu-402 as the catalytic residue. Post-translational modification analysis identified three N-glycosylation sites and seven disulfide bonds crucial for structural stability. Genetic variant analysis revealed nine known single nucleotide polymorphisms, including the clinically significant Q279R variant (rs17576) associated with intervertebral disc disease. Secondary structure prediction indicates 15 α-helices, 48 β-strands, and 6 turns, with structured regions comprising 68.3% of the protein. Protein-protein interaction network analysis identified 16 binding partners, including tissue inhibitors of metalloproteinases (TIMPs) and extracellular matrix components. This comprehensive analysis provides a foundation for understanding MMP9 structure-function relationships and its role in human diseases